| |
Company
Roster
|
|
Total
Insiders : |
49 |
|
|
|
Total
Direct Shares :
|
24,618,217 |
|
|
Total
Indirect Shares :
|
14,192,813 |
| |
%
Held by Insiders:
|
20.09% |
|
|
| |
| Filer's Name |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
  Henderson John T |
Director |
2024-04-25 |
32,070 |
2024-04-25 |
83 |
| Malik Fady Ibraham |
EVP Research & Development |
2024-04-12 |
138,417 |
|
0 |
| Callos Andrew |
EVP, Chief Commercial Officer |
2024-03-14 |
63,887 |
2022-02-16 |
0 |
| Blum Robert I |
President & CEO, Director |
2024-03-14 |
461,221 |
2024-03-14 |
4,166 |
| Wong Robert |
VP, Chief Accounting Officer |
2024-03-14 |
29,664 |
2020-03-06 |
0 |
| Smith Sandford D |
Director |
2024-01-02 |
18,801 |
2020-06-12 |
0 |
| Wysenski Nancy |
Director |
2024-01-02 |
17,156 |
2021-01-04 |
0 |
| Wierenga Wendall D |
Director |
2024-01-02 |
18,727 |
2020-04-28 |
0 |
| Harrington Robert Arthur |
Director |
2024-01-02 |
11,521 |
2022-05-10 |
0 |
| Kaye Edward M. Md |
Director |
2024-01-02 |
19,317 |
2020-10-05 |
0 |
| Bhanji Muna |
Director |
2023-07-07 |
14,031 |
2021-05-12 |
0 |
| Costa Santo J |
Director |
2023-05-10 |
15,000 |
2017-08-29 |
0 |
| Parshall B Lynne |
Director |
2023-05-10 |
15,000 |
2020-06-22 |
0 |
| Jaw Ching |
SVP Finance & CFO |
2023-03-06 |
57,346 |
2018-02-27 |
0 |
| Schlossberg Mark A |
SVP - Legal & General Counsel |
2022-03-15 |
103,408 |
2020-03-06 |
0 |
| Cragg David |
Chief HR & Admin Officer |
2022-03-07 |
153,233 |
2012-09-04 |
0 |
| Califf Robert |
Director |
2022-01-03 |
6,003 |
|
0 |
| Gage L Patrick |
Director |
2021-11-08 |
28,932 |
2021-11-08 |
1,850 |
| Lampert Mark N |
See Explanation of Responses |
2020-12-09 |
463,244 |
2019-12-10 |
0 |
| Mcdowell Caryn Gordon |
GC & Chief Compliance Officer |
2018-02-28 |
32,548 |
|
0 |
| Roddy Peter S |
SVP Finance & CAO |
2018-02-27 |
21,520 |
2018-02-27 |
0 |
| Morgan Bradley Paul |
SVP Drug Discovery & Early Dev |
2017-08-31 |
46,441 |
|
0 |
| Wolff Andrew A |
SVP & CMO |
2017-02-28 |
47,255 |
2012-09-04 |
0 |
| Schnieders Elisabeth |
Sr. VP, Business Development |
2017-02-28 |
43,919 |
|
0 |
| Barbari Sharon Surrey |
EVP, Finance & CFO |
2017-02-28 |
40,323 |
2009-11-16 |
0 |
| Charpentier Bonnie |
SVP Regulatory & Compliance |
2017-02-28 |
29,004 |
2017-02-28 |
0 |
| Dart Kenneth Bryan |
10% Owner |
2014-02-25 |
2,883,845 |
2014-02-25 |
0 |
| Eastern Capital Ltd |
10% Owner |
2012-06-20 |
14,303,071 |
|
0 |
| Sabry James H |
Former Executive Chairman |
2010-06-03 |
0 |
2009-06-29 |
49,550 |
| Rabson Michael |
SVP Business Dev/Legal & GC |
2009-12-18 |
20,043 |
|
0 |
| Morgans David J Jr |
EVP-Preclinical R&D |
2009-10-01 |
42,000 |
|
0 |
| Spudich James A |
Director |
2008-04-25 |
180,600 |
|
0 |
| Trautman Jay K |
VP, Discovery Research |
2007-08-10 |
47,896 |
|
0 |
| Hemisphere Private Equity Partners Charitable Trus |
10% Owner |
2004-05-04 |
0 |
2004-05-04 |
1,765,683 |
| Dalal Yogen K |
N/A |
2004-05-04 |
1,876,358 |
2004-05-04 |
13,705 |
| Sevin Rosen Vii Affiliates Fund Lp |
10% Owner |
2004-04-29 |
24,050 |
2004-04-29 |
0 |
| Sevin Rosen VIII Affiliates Fund Lp |
10% Owner |
2004-04-29 |
15,421 |
2004-04-29 |
0 |
| Dow Stephen M |
Director |
2004-04-29 |
0 |
2012-11-14 |
1,566,052 |
| Rutter William J |
Director |
2004-04-29 |
172,413 |
2004-04-29 |
0 |
| Sevin Rosen Fund Vii Lp |
10% Owner |
2004-04-29 |
625,950 |
2004-04-29 |
0 |
| Sevin Rosen Fund VIII Lp |
10% Owner |
2004-04-29 |
755,631 |
2004-04-29 |
0 |
| Sevin Rosen Vi Affiliates Fund Lp |
10% Owner |
2004-04-29 |
127,235 |
2004-04-29 |
0 |
| Schmertzler Michael |
Director |
2004-04-29 |
0 |
2010-06-03 |
4,340,923 |
| Schuele Alan R |
10% Owner |
2004-04-29 |
0 |
2004-04-29 |
3,164,003 |
| Srb Associates Vii Lp |
10% Owner |
2004-04-29 |
0 |
2004-04-29 |
650,000 |
| Srb Associates VIII Lp |
10% Owner |
2004-04-29 |
0 |
2004-04-29 |
771,052 |
| Srb Associates Vi Lp |
10% Owner |
2004-04-29 |
0 |
2004-04-29 |
1,742,951 |
| Sevin Rosen Fund Vi Lp |
10% Owner |
2004-04-29 |
1,615,716 |
2004-04-29 |
0 |
| Heidrich A Grant III |
Director |
2004-04-28 |
0 |
2004-11-29 |
122,795 |
|
0.54 (0.83%) 
